Neogen (NEOG) Current Deferred Revenue (2021 - 2026)
Neogen (NEOG) recorded quarterly Current Deferred Revenue of $3.9 million in Q1 2026, up 0.67% quarter-over-quarter from $3.9 million in Q4 2025, and down 32.4% on a YoY basis from $5.8 million in Q1 2025.
Neogen (NEOG) Current Deferred Revenue (2021 - 2026) Analysis & Trends
Neogen's Current Deferred Revenue history runs 6 years deep, the most recent figure standing at $3.9 million for Q1 2026.
- In Q1 2026, Current Deferred Revenue fell 32.4% year-over-year to $3.9 million; the TTM figure through Feb 2026 stood at $3.9 million (down 32.4% YoY), while the FY2025 annual figure was $5.6 million, up 20.9% from the prior year.
- Current Deferred Revenue was $3.9 million for Q1 2026 at Neogen, up from $3.9 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $6.8 million in Q1 2023 to a low of $3.8 million in Q3 2023.
- Historically, Current Deferred Revenue has averaged $5.1 million across 5 years, with a median of $5.5 million in 2022.
- The sharpest annual moves came in 2022 and 2026: Current Deferred Revenue surged 60.4% in 2022, then sank 32.4% in 2026.
- A 5-year view of Current Deferred Revenue shows it stood at $5.1 million in 2022, then fell by 7.95% to $4.7 million in 2023, then advanced by 20.77% to $5.7 million in 2024, then sank by 31.45% to $3.9 million in 2025, then increased by 0.67% to $3.9 million in 2026.
- The last three Current Deferred Revenue figures came in at $3.9 million (Q1 2026), $3.9 million (Q4 2025), and $5.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Neogen | 2.03 Bn | 1.87 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 3.90 Mn |
| Nov 30, 2025 | 3.87 Mn |
| Aug 31, 2025 | 5.82 Mn |
| May 31, 2025 | 5.60 Mn |
| Feb 28, 2025 | 5.77 Mn |
| Nov 30, 2024 | 5.65 Mn |
| Aug 31, 2024 | 5.64 Mn |
| May 31, 2024 | 4.63 Mn |
| Feb 29, 2024 | 5.49 Mn |
| Nov 30, 2023 | 4.68 Mn |
| Aug 31, 2023 | 3.79 Mn |
| May 31, 2023 | 4.62 Mn |
| Feb 28, 2023 | 6.77 Mn |
| Nov 30, 2022 | 5.08 Mn |
| Aug 31, 2022 | 5.46 Mn |
| May 31, 2022 | 5.46 Mn |
| May 31, 2021 | 3.40 Mn |